Search
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 8 of 8 items.
Health Canada is updating the labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines
… updated 2021-11-09 Summary Product Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines Issue Health products - … to the product labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines. The Department is updating … Health Canada is also updating the label of the Vaxzevria (AstraZeneca) COVID-19 vaccine to provide additional …
AlertPublic advisory | 2021-11-09
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
… (CLS) have been reported following vaccination with AstraZeneca COVID-19 Vaccine. A history of CLS was noted in some of the cases. A fatal outcome has been reported. AstraZeneca COVID-19 Vaccine and COVISHIELD (the version of the AstraZeneca COVID-19 Vaccine manufactured by the Serum …
AlertHealth professional risk communication | 2021-06-29
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia
… been observed very rarely following vaccination with the AstraZeneca COVID-19 Vaccine. Health Canada has assessed the … data on the reported events and has determined that the AstraZeneca COVID-19 Vaccine and COVISHIELD (the version of the AstraZeneca COVID-19 Vaccine manufactured by the Serum …
AlertHealth professional risk communication | 2021-03-24
Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines
… number: RA-75389 Last updated: 2021-06-29 Summary Product: AstraZeneca and COVISHIELD COVID-19 vaccines Issue: Health … is updating the product monographâor labelâfor the AstraZeneca and COVISHIELD COVID-19 vaccines to add capillary … with a history of capillary leak syndrome to not get the AstraZeneca or COVISHIELD COVID-19 vaccine. The label has …
AlertPublic advisory | 2021-06-29
Adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccine
… adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccine, and would like to reassure … these events. To date, no adverse events related to the AstraZeneca COVID-19 vaccine, or the version manufactured by … temporarily paused the use of specific batches of the AstraZeneca vaccine or use of the AstraZeneca vaccine …
AlertPublic advisory | 2021-03-11
Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels
… information during the initial distribution of the AstraZeneca COVID-19 Vaccine. Audiences Healthcare … and healthcare professionals at identified points of use. AstraZeneca Canada Inc. (AstraZeneca) (the Canadian importer and distributor) is …
AlertHealth professional risk communication | 2021-03-01
Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels (US-Labelled Supply)
… information during the initial distribution of the AstraZeneca COVID-19 Vaccine (US-labelled vaccine supplies) … and healthcare professionals at identified points of use. AstraZeneca Canada Inc. (AstraZeneca) (the Canadian importer and distributor) is …
AlertHealth professional risk communication | 2021-03-31
Authorization of COVISHIELD with English-only Vial and Carton Labels
… COVISHIELD (manufactured by Serum Institute of India) and AstraZeneca COVID-19 VACCINE (manufactured by AstraZeneca) are ChAdOx1-S recombinant vaccines developed by AstraZeneca and the University of Oxford. Health Canada has …
AlertHealth professional risk communication | 2021-03-01